Cellular senescence—the accumulation of damaged, non-dividing cells—is a hallmark of aging and contributes to age-related diseases. One promising anti-aging strategy is enhancing autophagy, the cell's natural mechanism for clearing damaged components. This study investigated whether Salvia plebeia R. Br. extract (SPE), a traditional plant remedy, could boost autophagy and reverse aging phenotypes. The researchers combined in vitro experiments in human foreskin fibroblasts with in vivo work in D-galactose-treated mice, a model of accelerated aging.
In cell culture, SPE induced autophagy markers (elevated LC3-II and Beclin-1, reduced p62), enhanced autophagosome formation, and mitigated D-galactose-induced senescence by reducing SA-β-gal staining, senescence markers (p16, p21), and DNA damage (γ-H2AX foci). Critically, these benefits were Atg7-dependent—knocking out the Atg7 autophagy gene abolished the protective effects, demonstrating that autophagy induction was necessary for SPE's action. In aged mice, SPE improved physical function, reversed cellular senescence in tissues, enhanced antioxidant defenses, and notably improved cognitive performance while reducing tau accumulation in the brain. The extract showed good tolerability with no apparent toxicity over 12 weeks.
Chemical profiling identified rosmarinic acid (RA), a polyphenol, as the major bioactive constituent; isolated RA recapitulated key autophagy and senescence effects in vitro. This provides a mechanistic anchor and potential therapeutic lead. However, significant limitations exist: the work is almost entirely preclinical (no human studies), the D-galactose mouse model is somewhat artificial, and long-term efficacy in normal aging remains untested. The paper also does not clarify dosing optimization, bioavailability of the extract in vivo, or whether effects persist beyond 12 weeks.
This study fits within the growing interest in plant-derived geroprotectors and autophagy enhancers (analogous to rapamycin or metformin). The Atg7-dependent mechanism is encouraging and the cognitive improvements hint at neurological relevance. However, the bridge from cell culture and accelerated-aging mice to human healthy aging is substantial. The work would benefit from independent replication, longer-term follow-up studies, and human proof-of-concept trials before clinical claims are made.
For the longevity research field, this adds to the evidence that botanical compounds can modulate autophagy, but does not yet establish clinical utility or superiority over existing approaches. The identification of rosmarinic acid is useful for future drug development, though RA itself is not novel and has been studied in other contexts.
0 Comments
Log in to join the discussion.